Expense Ratio History

CNCR expense ratio history

Range Cancer Therapeutics ETF

Fund company
ETF Series Solutions
Type
ETF

0.79%

In basis points
79 basis points
Yearly cost per $10,000
$79
Prospectus dated
21 December 2024, filed with the SEC; rounded to 0.01%

Fee over time

CNCR expense ratio: read at 0.79% on 21 Dec 2024.0.00%0.50%1.00%1.50%Sep 2015Apr 2017Nov 2018Jun 2020Jan 2022Aug 20230.79% on 21 Dec 2024
CNCR expense ratio: read at 0.79% on 21 Dec 2024.0.00%0.50%1.00%1.50%Sep 2015Nov 2018Jan 20220.79% on 21 Dec 2024
Each dot is a prospectus filed with the SEC or a date we read the fee from a source. The fee hasn't changed between them.

Every figure we've recorded

DateFeeWhat happened
21 Dec 2024 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2024-12-21 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
29 Dec 2023 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2023-12-29 (form 497), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 497
20 Dec 2022 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2022-12-20 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
31 Dec 2021 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2021-12-31 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
31 Dec 2020 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2020-12-31 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
31 Dec 2019 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2019-12-31 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
31 Dec 2018 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2018-12-31 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
31 Dec 2017 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2017-12-31 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
20 Dec 2016 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2016-12-20 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS
18 Sep 2015 0.79% In the prospectusTotal annual fund operating expenses in the prospectus dated 2015-09-18 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS

What this fee costs

Change the amount, years or return. The estimate keeps the fee at 0.79% and the return steady each year, the same assumptions as the cost example in a fund's prospectus.

$981 in fees over 10 years

After fees, $10,000 grows to $15,075.

Fees paid on $10,000 at 5% a year
AfterFees paid
1 year$81
3 years$253
5 years$440
10 years$981

How we read this figure

The figure is the total annual fund operating expenses line of the fee table in the fund's prospectus, as tagged in the fund company's filing with the SEC. The SEC publishes these figures rounded to four decimal places, so 0.015% appears as 0.02%. The fund company's own page may show a more precise number.

SEC filings give 10 prospectuses for this share class since 2015. Each one is listed above with a link to the filing.

How we read fees

More ETF Series Solutions funds

The cheapest of 100. All ETF Series Solutions funds.